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Telomerase is reactivated in lung cancer cells, the most prevalent cancer worldwide, but not normal 
cells. Therefore, targeting it, preferably with natural compounds derive from medicinal plant such as 
curcumin, could have important effect on treatment of lung cancer. Curcumin, derived from Curcuma 
longa rhizome, has many anti-cancer activities. Therefore, the main objective of current work was to 
study inhibitory effect of C. longa total extract on telomerase in A549 lung cancer cell line as in vitro 
model of lung cancer. First, total extract of C. longa were prepared by n-hexane, methanol and 
dichloromethane. Then, cytotoxic effect of n-hexane phase was studied on A549 lung cancer cell line 
with 24, 48 and 72 h MTT assays. Finally, after determination of IC50, cells were treated with n-hexane 
extract and TRAP (Telomeric Repeat Amplification Protocol) assay was done to measure amount of 
relative telomerase inhibition by the extract. Data analysis showed that n-hexane extract of C. longa has 
dose-dependent cytotoxic effect on A549 lung cancer cell line with IC50 = 0.23 - 0.28 mg/ml and the 
extract inhibits telomerase activity with dose-dependent manner. In conclusion, n-hexane extract of C. 
longa has cytotoxic and telomerase-inhibitory effect on cell line A549 and could be exploited as 
potential source for developing novel drugs against lung cancer. 
 





Telomerase is a ribonucleoprotein reverse transcriptase 
which maintains telomeric ends of eukaryotic chromo-
somes during DNA replication. It has been shown that 
telomerase is active in more than 85% of cancers 
including lung cancer but not normal cells (Lingner et al., 
1995; Kim, 1997). On the other hand, lung cancer is the 
most prevalent cancer worldwide (Jemal et al., 2007). 
Therefore, targeting the telomerase in this cancer could 
be promising step in its treatment. Different agents have 
been proposed for telo-merase inhibition (Strahl and 
Blackburn, 1996; Damm et al., 2001; Zou et al., 2006; 
Massard et al., 2006; Nakamura et al., 2005; Mizushina 
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complications (Mittal et al., 2004) and it is necessary to 
seek alternative telomerase-inhibiting agents, preferably 
natural compounds such as curcumin.  
Curcuma longa is a medicinal plant which its consti-
tuents, especially curcumin, has diverse anti-cancer pro-
perties including anti-telomerase action (Sanjay et al., 
2007; Anand et al., 2008). Anti-telomerase activity of pure 
curcumin has been studied previously in some cancer 
cells other than lung cancer cells (Cui et al., 2006; 
Chakraborty et al., 2006; Ramachandran et al., 2002; 
Singh and Singh, 2009; Mukherjee et al., 2007). How-
ever, to date any study for investigating the effect of 
curcuma total extract on telomerase in the lung cancer 
cells remains unperformed. Therefore, the main aim of 
current work was to study the effect of C. longa total 
extract on telomerase activity in A549 lung cancer cell 
line as in vitro model of lung cancer for its possible thera-










100 g powder of C. longa rhizome was dissolved in 200 ml n-
hexane and solution was shaken for 4 h at 45°C. Then, supernatant 
was transferred to a tube. This step was performed three times. In 
the next step, residue of n-hexane extraction was dissolved in 200 
ml dichloromethane instead of n-hexane and same steps repeated 
using dichloromethane. In the next step, debris of previous extrac-
tion step with dichloromethane was dissolved in 200 ml methanol 
and at the same way supernatant was collected. Finally, solvents of 
all three phases were dried by rotatory-evaporator and remained 
powders were stored at - 20°C until used. 
 
 
Selection of appropriate phase 
 
Based on the fact that Curcuminoids have maximum absorbance at 
m = 420 - 430 nm (Jayaprakasha et al., 2005), the curcuminoids 
content of n-hexane, dichloromethane and methanol phases of 
extract was determined spectrophotometrically. Briefly, ODs of 
0.038, 0.0304, 0.019, 0.0152, 0.0076 and 0.0019 mg/ml solutions of 
pure curcumin (sigma) dissolved in 10% DMSO and ODs of 0.0038 
mg/ml solutions of extract phases in 10% DMSO were determined 
in m = 420 nm and m = 430 nm with three times reading in the 
spectrophotometer. Then, standard curve was plotted using mean 
of pure curcumin OD×100. Finally, relative curcumin content of 
phases was determined according to standard curve. 
 
 
Cell culture and cytotoxicity  
 
A549 lung cancer cell line (kindly dedicated from pharmaceutical 
nanotechnology research center, Tabriz University of Medical 
Sciences, Tabriz, Iran) were cultured in RPMI1640 (Gibco, Invitro-
gen, UK) supplemented with 10% heat-inactivated fetal bovine 
serum (FBS) (Gibco, Invitrogen, UK), 2 mg/ml sodium bicarbonate, 
0.05 mg/ml penicillin G (Serva co, Germany), 0.08 mg/ml 
streptomycin (Merck co, Germany) and incubated in 37°C with 
humidified air containing 5% CO2. After culturing sufficient amount 
of cells, cytotoxic effect of n-hexane extract was studied by 24, 48 
and 72 h MTT assays (Carmichael et al., 1987). Briefly, 1000 
cell/well were cultivated in a 96 well plate. After 24 h incubation in 
37°C with humidified atmosphere containing 5% CO2, cells were 
treated with serial concentrations of n-hexane extract of C. longa (0 
mg/ml to 0.57 mg/ml)  for 24, 48 and 72 h in the quadruplicate man-
ner as cells which received 0 mg/ml extract + 200 µl culture medium 
containing 10% DMSO  served as control. After incubation, the 
medium of all wells of plate were exchanged with fresh medium and 
cells were leaved for 24 h in incubator. Then, medium of all wells 
were removed carefully and 50 l of 2 mg/ml MTT (Sigma co, 
Germany) dissolved in PBS was added to each well and plate was 
covered with aluminum foil and incubated for 4.5 h. After removing 
of wells’ content, 200 l pure DMSO was added to wells. Then, 25 
µl Sorensen’s glycine buffer was added and immediately absor-
bance of each well was read in 570 nm using ELx800 Microplate 
Absorbance Reader (Bio-Tek Instruments) with reference wave-





After determination of IC50, 1×106 cells were treated with serial 
concentrations of n-hexane extract (0.028, 0.057, 0.114, 0.142, 
0.171 and 0.199 mg/ml). For control cells, the same volume of 10%  




DMSO without n-hexane extract was added to flask of control cells. 
Then, culture flasks were incubated in 37°C containing 5% CO2 with 
humidified atmosphere incubator for 24 h exposure duration.  
 
 
Telomeric repeat amplification protocol (TRAP) assay 
 
After 24 h, cells were harvested, their total protein were extracted 
according to instructions of TeloTAGGG Telomerase PCR ELISA 
PLUS package (Cat. No. 12 013 789 001, Roche Applied Science, 
Germany) and quantity of total protein was determined for each 
sample by Quick Start™ Bradford Protein Assay (Cat. No. 500-
0206, Bio-Rad Laboratories, Inc., USA). Finally, for determining 
relative telomerase activity in the samples, we used Holt PCR-
ELISA based TRAP assay method (Holt et al., 1996) according to 
instructions of TeloTAGGG Telomerase PCR ELISAPLUS kit and our 
previous work (Zarghami and Asadi, 2007). First, negative control 
for each sample was constructed by heating at 95°C for 20 min. 
Then, 50 µl reaction mixture (5 µg extracted total protein, 5 µl 
dNTPs, 60 ng from each primer, 5 µl Internal Standard and 16 µl 
double-distilled nuclease free water) for each sample was added in 
a new 0.5 ml microtube.  
Then, microtubes were transferred to Eppendorf PCR thermal 
cycler and a combinatory elongation/PCR reaction was performed 
[1 cycle for 20 min at 25°C (primer elongation); 1 cycle for 20 min at 
95°C (telomerase inactivation); 30 cycles for 30 s at 94°C, 30 s at 
50°C and 90 s at 72°C and 1 cycle for 10 min at 72°C (PCR)]. 
Then, PCR amplicons were detected by ELISA-based hybridization. 
For this purpose, 3 µl PCR products were immobilized on strep-
tavidin coated modules and incubated for 2 h at room temperature. 
Then, module wells were washed three times and horseradish 
peroxidase-conjugated anti-digoxigenin antibody was added to 
wells. After that, substrate solution containing 3,3',5,5' tetra methyl 
benzene (TMB) was added to wells, wells incubated in room tempe-
rature for 20 min for color development and more color develop-
ment was stopped. Finally, absorbance of developed blue color was 
measured at 450 nm by STAT-FAX 2100 ELISA reader (with a 





For data analysis of MTT assays, mean OD of each well was calcu-
lated. Then, OD of tests and controls was corrected by subtracting 
mean OD of tests and controls from mean OD of blanks (medium 
alone). Then, percent of viability of control was calculated according 
this formula: percent of viability of control = corrected mean OD of 
test/corrected control×100. Finally, graph of results was plotted 
using SPSS 16.0 and IC50 (half maximal inhibitory concentration) 
of n-hexane extract on A549 was calculated. 
Relative telomerase activity percent (%RTA) of each sample was 
calculated according to instructions of TeloTAGGG Telomerase 
PCR ELISAPLUS kit. Then, %RTA of control cell was calculated for 





Data analysis of spectrophotometric measurement of 
extracted phases curcuminoids content showed that n-
hexane phase has more curcumin than methanol and 
dichloromethane phases and dichloromethane phase has 
the lowest content of curcuminoids (Figure 1 and Table 
1). Therefore, we investigated the effect of n-hexane extract  
 










Table 1. Mean absorbances of pure curcumin, n-hexane extract, methanol extract and dichloromethane extract solutions in max = 420 
nm and max = 430 nm. 
 





Conc. (mg/ml) 0.0019 0.0076 0.0152 0.019 0.0304 0.038 0.0038 0.0038 0.0038 
max  = 420 nm 0.0025 0.0049 0.0108 0.0097 0.0143 0.0207 0.0120 0.0038 0.0006 
max  = 430 nm 0.0024 0.0050 0.01055 0.0096 0.0143 0.0207 0.0123 0.0037 0.0008 




of C. longa on telomerase activity in the A549 cell line. 
Data analysis of cytotoxicity assay showed that IC50 of n-
hexane extract on A549 lung cancer cell line is 0.28, 0.27 
and 0.23 mg/ml for 24, 48 and 72 h MTT assays, 
respectively (Figure 2).  Figure 2 shows that IC50 of n-
hexane extract on A549 lung cancer cell line is dose-
dependent but not time dependent. Therefore, we investi-
gated telomerase-inhibitory effect of n-hexane extract on 
A549 for 24 h exposure time (Figure 3). Morphological 
analysis showed no significant difference between control 
and treated cells. 
Data analysis obtained from TRAP assay showed that 
n-hexane extract of C. longa inhibits telomerase activity 
dose-dependently and doses higher than 0.114 mg/ml 
completely inhibit telomerase relative activity (Figure 4, 
Tables 2 and 3).  Table 2 shows that concentration of 
0.142 mg/ml is the least effective dose for complete inhi-
bition of telomerase activity in A549 lung cancer cell line. 
In addition, in this dose telomerase activity was inhibited 
46.30 folds in comparison with untreated cells. Therefore, 
dose of 0.142 mg/ml may be a cut-off point for telo-
merase inhibition  by  n-hexane  extract  in  the A549  cell  
 




             
 
         



































   
Figure 2. Cytotoxic effect of n-hexane extract on A549 lung cancer cell line after 24 h (A), 48 h (B) and 72 h (C) exposure. 
(D). IC50 of n-hexane extract of Curcuma longa on A549 tumor cell line after 24, 48 and 72 h treatment. 
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In the present study, total extract used instead of pure 
curcumin. Because, beside synergistic effects of cur-
cuminoids on each other in a solution (Deshpande and 
Maru, 1995) and based on Jayaprakasha et al. (2005) 
report, extraction of pure curcumin from rhizome of C. 
longa is time consumable and needs for using HPLC 
methods. 
In the current work, MTT assay showed that n-hexane 
extract of C. longa has dose-dependent but not time-
dependent cytotoxicity on the A549 lung cancer cell line 
(IC50 = 0.23 to 0.30 mg/ml). This finding is in accordance 
with result of a study (Radhakrishna et al., 2004) in which 
pure curcumin had dose-dependent but not time-depen-
dent cytotoxicity on A549, but IC50 of pure curcumin was 
0.01841 mg/ml (50 M) for 24 h exposure in that study. In 
addition, results of same study showed IC50 = 0.01474 
mg/ml (40 M) of pure curcumin on H1299 cells 
(Radhakrishna et al., 2004). This difference in the IC50 
may be due to purity of curcumin and existence of other 
substances other than curcumin which may interfere with 
action of curcumin. Therefore, there is need for separa-
tion and further study of n-hexane extraction constituents 
in the future. Shi et al. (2006) showed that 40 M 
curcumin inhibits growth of the human epithelium ovarian 
cancer cell line Ho-8910 in vitro by 52% for 48 h expo-
sure (P < 0.05) (Shi et al., 2006). However, results of 
current work demonstrated that IC50  of  C. longa  extract  
 




 Correlation between different concentrations of n-hexane extract of Curcuma longa and   
Figure 4. Correlation between different concentrations of n-hexane extract of Curcuma longa and telomerase activity in 




Table 2. Determination of telomerase activity in A549 tumor 
cells treated with different concentrations of n-hexane extract 
of Curcuma longa. 
 









*The cut off point of being positive (+) and negative (-) was 
calculated based on following formula: 
OD of sample - OD of negative control = A 
If A > 2× (OD of negative control), then, telomerase activity 




is about 0.26 mg/ml in  A549  lung  cancer  cell  line. This  
different finding may be is due to different behavior of two 
cells in response to curcumin and shows that these 
cancers may differently response to exposure with cur-
cumin in vivo.  
Currently there are different types of standard treat-
ment methods for lung cancer patients such as surgery, 
radiation, chemotherapy, laser therapy, photodynamic 
therapy (PDT), biologic therapy and gene targeted the-
rapy (Thatcher, 2008). However, there are harsh side 
effects about all (Geamanu, 2008). Therefore, with regar-
ding to these undesirable effects and result of current 
study, it seems that C. longa may be an appropriate 
source for developing novel drugs against lung cancer 
and can be a safer alternative for current treatment re-
gimens. 
In conclusion, results of current study showed that n-
hexane extract of C. longa has inhibitory effect on telo-
merase in the A549 lung cancer cell line. Inhibition of 
telomerase by n-hexane extract of C. longa in these cells 
is reported for the first time and even any study, in  which  
 




Table 3. Comparison Between fold increases of telomerase inhibition by different 
concentrations of n-hexane extract in A549 lung cancer cell line. 
 
Concentration of n-
hexane extract (mg/ml) 
RTA of control 
cells (%) 
Fold increase in inhibition 
of telomerase activity 
0.0 100.0 1 
0.028 78.9 1.27 
0.057 58.26 1.72 
0.114 27.13 3.69 
0.142 2.16 46.30 
0.171 2.0 50 




the effect of pure curcumin on the telomerase in the A549 
has been investigated, has not been reported to date. 
However, similar works on other cell lines have been 
performed with pure curcumin on the other cell lines (Cui 
et al., 2006; Chakraborty et al., 2006; Ramachandran et 
al., 2002). Results of these studies have showed that 
pure curcumin has inhibitory effect on telomerase. Inhi-
bition of telomerase by pure curcumin based on these 
studies, approve results of current research. Because 
based on our work n-hexane extract of C. longa which 
contains curcumin, inhibited telomerase dose-
dependently in A549 tumor cell lines. Therefore, it can 
have potentially telomerase-targeting compounds, espe-
cially for exploiting in treatment of lung cancer. 
Current work demonstrated that n-hexane crude extract 
of C. longa has potent anti-growth effect on A549 and 
dose-dependently inhibits telomerase in this cell line as in 
vitro model of NSCLC. Therefore, C. longa can be natural 
potent chemopreventive and chemotherapeutic plant for 
NSCLC patients and constituents of its n-hexane extract 
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